Methodist Fremont Health | |
450 East 23rd St, Fremont, Nebraska 68025 | |
(402) 727-3381 | |
Name | Methodist Fremont Health |
---|---|
Type | Acute Care Hospital |
Location | 450 East 23rd St, Fremont, Nebraska |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 280077 |
NPI Number | 1033698543 |
Organization Name | METHODIST FREMONT HEALTH |
Address | 450 E 23rd St, Fremont, NE 68025 |
Hospital Type | General Acute Care Hospital - Rural |
Phone Number | 402-721-1610 |
News Archive
Valley Behavioral Health is launching a technology-based program to better understand a patient's health status and predict likely receptivity and compliance to treatment - all of which is designed to greatly improve healthcare services to its patients throughout its regional service area.
StemCells, Inc. announced today that it has commenced patient recruitment for a Phase I clinical trial designed to test the safety and preliminary efficacy of its HuCNS-SC® purified human neural stem cells in Pelizaeus-Merzbacher Disease (PMD), a neurological disorder that primarily afflicts children. The study is being conducted at the University of California, San Francisco (UCSF) Children's Hospital, one of the leading medical centers in the United States for neonatology, pediatric neurology and neurosurgery.
As the Great Recession wiped out nearly 9 million jobs and 19 trillion dollars in wealth from U.S. households, American families experienced another steep decline - they had fewer children.
Oxford Gene Technology, The Molecular Genetics Company, is inviting attendees of the British Society for Genetic Medicine annual conference to its seminar entitled ‘Approaches to tumour screening and therapy stratification: case studies in Non-Small Cell Lung Cancer' on Monday 22nd September, 13.10-13.50, room 2N.
› Verified 4 days ago
NPI Number | 1821037938 |
Organization Name | FREMONT HEALTH |
Doing Business As | FREMONT HEALTH MEDICAL CENTER |
Address | 450 E 23rd St, Fremont, NE 68025 |
Hospital Type | General Acute Care Hospital - Rural |
Phone Number | 402-721-1610 |
News Archive
Valley Behavioral Health is launching a technology-based program to better understand a patient's health status and predict likely receptivity and compliance to treatment - all of which is designed to greatly improve healthcare services to its patients throughout its regional service area.
StemCells, Inc. announced today that it has commenced patient recruitment for a Phase I clinical trial designed to test the safety and preliminary efficacy of its HuCNS-SC® purified human neural stem cells in Pelizaeus-Merzbacher Disease (PMD), a neurological disorder that primarily afflicts children. The study is being conducted at the University of California, San Francisco (UCSF) Children's Hospital, one of the leading medical centers in the United States for neonatology, pediatric neurology and neurosurgery.
As the Great Recession wiped out nearly 9 million jobs and 19 trillion dollars in wealth from U.S. households, American families experienced another steep decline - they had fewer children.
Oxford Gene Technology, The Molecular Genetics Company, is inviting attendees of the British Society for Genetic Medicine annual conference to its seminar entitled ‘Approaches to tumour screening and therapy stratification: case studies in Non-Small Cell Lung Cancer' on Monday 22nd September, 13.10-13.50, room 2N.
› Verified 4 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Valley Behavioral Health is launching a technology-based program to better understand a patient's health status and predict likely receptivity and compliance to treatment - all of which is designed to greatly improve healthcare services to its patients throughout its regional service area.
StemCells, Inc. announced today that it has commenced patient recruitment for a Phase I clinical trial designed to test the safety and preliminary efficacy of its HuCNS-SC® purified human neural stem cells in Pelizaeus-Merzbacher Disease (PMD), a neurological disorder that primarily afflicts children. The study is being conducted at the University of California, San Francisco (UCSF) Children's Hospital, one of the leading medical centers in the United States for neonatology, pediatric neurology and neurosurgery.
As the Great Recession wiped out nearly 9 million jobs and 19 trillion dollars in wealth from U.S. households, American families experienced another steep decline - they had fewer children.
Oxford Gene Technology, The Molecular Genetics Company, is inviting attendees of the British Society for Genetic Medicine annual conference to its seminar entitled ‘Approaches to tumour screening and therapy stratification: case studies in Non-Small Cell Lung Cancer' on Monday 22nd September, 13.10-13.50, room 2N.
› Verified 4 days ago
Methodist Fremont Health Acute Care Hospital Location: 450 East 23rd St, Fremont, Nebraska 68025 Phone: (402) 727-3381 |